Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Cancers
|
March 10, 2022
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
Maike Trommer, Anne Adams, Eren Celik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2022
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, et al.
International Journal of Radiation Biology
|
May 27, 2021
CyberKnife radiation therapy as a platform for translational mouse studies
Martha Kiljan, Sabrina Weil, Andres Vásquez-Torres, et al.
Blood
|
April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial
Anne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 3, 2025
Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational study
Simon Trommer, Jörg Andreas Müller, Michael Oertel, et al.
European Geriatric Medicine
|
July 12, 2026
Integration of geriatric assessment-guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): a feasibility approach
Rea Sujin Mayland, Merlin Deterding, Filippo Maria Verri, et al.
Cancer Immunology Research
|
July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Sebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
The Lancet. Oncology
|
February 26, 2017
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP<sub>escalated</sub> alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Andreas Lohri, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
JAMA Oncology
|
May 1, 2020
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
Paul J Bröckelmann, Helen Goergen, Ulrich Keller, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Cancers
|
March 10, 2022
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
Maike Trommer, Anne Adams, Eren Celik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2022
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, et al.
International Journal of Radiation Biology
|
May 27, 2021
CyberKnife radiation therapy as a platform for translational mouse studies
Martha Kiljan, Sabrina Weil, Andres Vásquez-Torres, et al.
Blood
|
April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial
Anne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 3, 2025
Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): a multicenter retrospective observational study
Simon Trommer, Jörg Andreas Müller, Michael Oertel, et al.
European Geriatric Medicine
|
July 12, 2026
Integration of geriatric assessment-guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): a feasibility approach
Rea Sujin Mayland, Merlin Deterding, Filippo Maria Verri, et al.
Cancer Immunology Research
|
July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
Sebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
The Lancet. Oncology
|
February 26, 2017
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP<sub>escalated</sub> alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Andreas Lohri, et al.
British Journal of Haematology
|
August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
JAMA Oncology
|
May 1, 2020
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
Paul J Bröckelmann, Helen Goergen, Ulrich Keller, et al.
Page
of 9